BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20194572)

  • 1. Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?
    Müller N; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):713-4. PubMed ID: 20194572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics.
    Debnath M; Venkatasubramanian G
    Curr Opin Psychiatry; 2013 Sep; 26(5):433-9. PubMed ID: 23867655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages.
    Mansur RB; Zugman A; Asevedo EM; da Cunha GR; Bressan RA; Brietzke E
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):247-60. PubMed ID: 22624729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics.
    Mondelli V; Howes O
    Psychopharmacology (Berl); 2014 Jan; 231(2):317-8. PubMed ID: 24337065
    [No Abstract]   [Full Text] [Related]  

  • 5. The question of pro-inflammatory immune activity in schizophrenia and the potential importance of anti-inflammatory drugs.
    Arolt V; Ambrée O
    Mod Trends Pharmacopsychiatry; 2013; 28():100-16. PubMed ID: 25224894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of epigenetics of schizophrenia].
    Nishioka M; Bundo M; Kasai K; Iwamoto K
    Nihon Rinsho; 2013 Apr; 71(4):605-9. PubMed ID: 23678586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction.
    Kinney DK; Hintz K; Shearer EM; Barch DH; Riffin C; Whitley K; Butler R
    Med Hypotheses; 2010 Mar; 74(3):555-63. PubMed ID: 19836903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of the treatment of depression and schizophrenia.
    Müller N
    Dialogues Clin Neurosci; 2017 Mar; 19(1):55-63. PubMed ID: 28566947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders.
    Müller N; Schwarz MJ
    Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():97-106. PubMed ID: 18516521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.
    Müller N
    Schizophr Bull; 2018 Aug; 44(5):973-982. PubMed ID: 29648618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia.
    Miller BJ; Buckley PF
    Psychiatr Clin North Am; 2016 Jun; 39(2):187-98. PubMed ID: 27216899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of statins for the management of immune reconstitution syndrome.
    Sun HY; Singh N
    Med Hypotheses; 2011 Mar; 76(3):307-10. PubMed ID: 20965666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-related genes up-regulated in schizophrenia brains.
    Saetre P; Emilsson L; Axelsson E; Kreuger J; Lindholm E; Jazin E
    BMC Psychiatry; 2007 Sep; 7():46. PubMed ID: 17822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling immune alterations in schizophrenia: can DNA methylation provide clues?
    Frydecka D; Karpiński P; Misiak B
    Epigenomics; 2014 Jun; 6(3):245-7. PubMed ID: 25111476
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment.
    Mongan D; Ramesar M; Föcking M; Cannon M; Cotter D
    Early Interv Psychiatry; 2020 Aug; 14(4):385-397. PubMed ID: 31368253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of schizophrenia, pruning, and epigenetics: a hypothesis and suggestion.
    Rosenthal R
    Med Hypotheses; 2011 Jul; 77(1):106-8. PubMed ID: 21477930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and molecular genetics].
    Andreassen OA; Steen VM
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2118-22. PubMed ID: 12555650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory strategies in coronary atherosclerosis.
    Burton PB; Daniel TO
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in schizophrenia: A question of balance.
    Leza JC; García-Bueno B; Bioque M; Arango C; Parellada M; Do K; O'Donnell P; Bernardo M
    Neurosci Biobehav Rev; 2015 Aug; 55():612-26. PubMed ID: 26092265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection.
    Pearce EL; Shen H
    Immunol Rev; 2006 Jun; 211():197-202. PubMed ID: 16824128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.